Songklanagarind Hospital

Institution (Healthcare)

Homepage Wikipedia ROR

Also Known As

Songklanagarind Hospital, โรงพยาบาลสงขลานครินทร์

771

Publications

23.7K

Citations

Authors

232

Concepts

About

Songklanagarind Hospital is a healthcare institution in Hat Yai, Thailand known for medicine, hepatitis, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	103	8K
2	Health Sciences	10	17	2K
3	Nursing	5	9	195
4	Engineering	2	3	92
5	Language Studies	1	2	56

Songklanagarind Hospital

771

Publications

23.7K

Citations

Page 1

	Year	Citations
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B George Lau, Teerha Piratvisuth, Kang Luo, New England Journal of Medicine	2005	1.5K
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study Jean‐Charles Soria, Daniel S.W. Tan, Rita Chiari, The Lancet MedicineBronchial NeoplasmAdvanced AlkFirst-line CeritinibCancer Treatment	2017	1.1K
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B Patrick Marcellin, George Lau, Ferruccio Bonino, New England Journal of Medicine	2004	1.1K
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Yun‐Fan Liaw, Jia‐Horng Kao, Teerha Piratvisuth, Hepatology International Hepatitis DHepatologyViral HepatitisGlobal HealthHepatitis B	2012	1K
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Yun‐Fan Liaw, Nancy Leung, Jia‐Horng Kao, Hepatology International	2008	869
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely, The Lancet Infectious Diseases Single-arm Open-label TrialAntifungal AgentAntifungal AgentsClinical MycologyMedicine	2016	676
International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009 Víctor Rosenthal, Dennis G. Maki, Silom Jamulitrat, American Journal of Infection Control Healthcare-associated InfectionHospital EpidemiologyJune 2009Data SummaryInfection Control	2010	510
MAIT cells are activated during human viral infections Bonnie van Wilgenburg, Iris Scherwitzl, Edward Hutchinson, Nature Communications	2016	509
Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B # † Maurizia Rossana Brunetto, F. Moriconi, Ferruccio Bonino, Hepatology	2008	481
Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B W. G. E. Cooksley, Teerha Piratvisuth, Shin‐Da Lee, Journal of Viral Hepatitis	2003	476

Page 1